Use of liposomes for the enhancement of the cytotoxic effects of cytosine arabinoside.
D000818:Animals; D001085:Arabinofuranosylcytosine Triphosphate / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage* / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy; D008081:Liposomes / Q000627:therapeutic use*; D051379:Mice; D008811:Mice, Inbred DBA; D014677:Pharmaceutical Vehicles; D010713:Phosphatidylcholines; D010718:Phosphatidylserines; D011247:Pregnancy; D014018:Tissue Distribution
D008081:Liposomes; D014677:Pharmaceutical Vehicles; D010713:Phosphatidylcholines; D010718:Phosphatidylserines; D003561:Cytarabine; D001085:Arabinofuranosylcytosine Triphosphate